Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0000950123-01-507811
Filing Date
2001-11-02
Accepted
2001-11-02 00:00:00
Documents
5
Period of Report
2000-12-31

Document Format Files

Seq Description Document Type Size
1 ICN PHARMACEUTICALS, INC. y54300e10-ka.txt 10-K/A 32064
3 EXCLUSIVE LICENSE AND SUPPLY AGREEMENT y54300ex10-21.txt EX-10.21 317369
4 AMENDMENT TO EXCLUSIVE LICENSE AND SUPPLY AGR. y54300ex10-32.txt EX-10.32 6113
5 AMENDMENT TO EXCLUSIVE LICENSE AND SUPPLY AGR. y54300ex10-33.txt EX-10.33 24825
6 AGREEMENT y54300ex10-34.txt EX-10.34 70451
  Complete submission text file 0000950123-01-507811.txt   452514
Mailing Address 3300 HYLAND AVE COSTA MESA CA 92626
Business Address 3300 HYLAND AVE COSTA MESA CA 92626 7145450100
ICN PHARMACEUTICALS INC (Filer) CIK: 0000930184 (see all company filings)

EIN.: 330628076 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-11397 | Film No.: 1774343
SIC: 2834 Pharmaceutical Preparations